Here's why more Americans are opting for a ‘sleep divorce?' [Fortune]
ResMed Inc. (NYSE: RMD) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer
ResMed Inc. (NYSE: RMD) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
I Took an At-Home Sleep Test and Was Shocked by the Results [CNET News]